Growth Metrics

Erasca (ERAS) Income towards Parent Company (2020 - 2026)

Erasca posted quarterly Income towards Parent Company of -$183.5 million for Q1 2026, down 492.46% year-on-year from $46.7 million in Q1 2025, and down 531.8% on a QoQ basis from -$29.0 million in Q4 2025.

Erasca (ERAS) has 7 years of Income towards Parent Company data on file, last reported at -$183.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 492.46% year-over-year to -$183.5 million; the trailing twelve-month figure through Mar 2026 stood at -$277.0 million (down 77.57% YoY), and the FY2025 full-year result was -$124.5 million, up 22.95% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$183.5 million, down from -$29.0 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$29.0 million in Q4 2025 and bottomed at -$183.5 million in Q1 2026.
  • The 5-year median for Income towards Parent Company is -$33.2 million (2023), against an average of -$49.2 million.
  • The widest annual swing landed in 2023, when Income towards Parent Company jumped 78.04%; it then slumped 492.46% in 2026.
  • A 5-year view of Income towards Parent Company shows it stood at -$135.2 million in 2022, then surged by 78.04% to -$29.7 million in 2023, then declined by 2.45% to -$30.4 million in 2024, then grew by 4.57% to -$29.0 million in 2025, then sank by 531.8% to -$183.5 million in 2026.
  • The last three Income towards Parent Company figures came in at -$183.5 million (Q1 2026), -$29.0 million (Q4 2025), and -$30.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Erasca 4.21 Bn 3.97 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -183.46 Mn
Dec 31, 2025 -29.04 Mn
Sep 30, 2025 -30.58 Mn
Jun 30, 2025 -33.88 Mn
Mar 31, 2025 -30.97 Mn
Dec 31, 2024 -30.43 Mn
Sep 30, 2024 -31.37 Mn
Jun 30, 2024 -63.20 Mn
Mar 31, 2024 -35.02 Mn
Dec 31, 2023 -29.70 Mn
Sep 30, 2023 -30.36 Mn
Jun 30, 2023 -31.78 Mn
Mar 31, 2023 -33.20 Mn
Dec 31, 2022 -135.25 Mn
Sep 30, 2022 -35.49 Mn
Jun 30, 2022 -35.61 Mn
Mar 31, 2022 -36.46 Mn
Dec 31, 2021 -30.97 Mn
Sep 30, 2021 -46.07 Mn
Jun 30, 2021 -28.21 Mn
Mar 31, 2021 -19.63 Mn
Dec 31, 2020 -66.93 Mn
Sep 30, 2020 -11.16 Mn
Jun 30, 2020 -7.25 Mn